Gut Microbiome Composition and Dynamics in Hospitalized COVID-19 Patients and Patients with Post-Acute COVID-19 Syndrome
International Journal of Molecular Sciences · 01.01.2024 · 25 (1) · 567
DOI: 10.3390/ijms25010567 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.01.2024. Verfasst von Monta Brīvība und 11 weiteren Autor:innen. Beteiligte Einrichtung: Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia. Hauptthemen laut MEDLINE: COVID-19, Gastrointestinal Microbiome. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund.
Abstract (Originalsprache)
The gut microbiome plays a pivotal role in the modulation of host responses during viral infections, and recent studies have underscored its significance in the context of coronavirus disease 2019 (COVID-19). We aimed to investigate the dynamics and compositional changes in the gut microbiome of COVID-19 patients, addressing both the acute phase and the recovery process, with a particular focus on the emergence of post-COVID-19 conditions. Involving 146 COVID-19 patients and 110 healthy controls, this study employed a shotgun metagenomics approach for cross-sectional and longitudinal analyses with one- and three-month follow-ups. We observed a decline in taxonomic diversity among hospitalized COVID-19 patients compared to healthy controls, while a subsequent increase in alpha diversity was shown during the recovery process. A notable contribution of Enterococcus faecium was identified in the acute phase of the infection, accompanied by an increasing abundance of butyrate-producing bacteria (e.g., Roseburia, Lachnospiraceae_unclassified) during the recovery period. We highlighted a protective role of the Prevotella genus in the long-term recovery process and suggested a potential significance of population-specificity in the early gut microbiome markers of post-acute COVID-19 syndrome. Our study represents distinctive gut microbiome signatures in COVID-19, with potential diagnostic and prognostic implications, pinpointing potential modulators of the disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.
ORCID-Profile: Monta Brīvība, Laila Silamiķele, Līga Birzniece, Laura Ansone, Maija Rozenberga, Ilze Elbere, Jānis Kloviņš
Förderung
- European Regional Development Fund
Zitieren
APA
Brīvība, M., Silamiķele, L., Birzniece, L., Ansone, L., Megnis, K., Silamiķelis, I., Pelcmane, L., Borisova, D., Rozenberga, M., Jagare, L., Elbere, I., & Kloviņš, J. (2024). Gut Microbiome Composition and Dynamics in Hospitalized COVID-19 Patients and Patients with Post-Acute COVID-19 Syndrome. International Journal of Molecular Sciences, 25(1), 567. https://doi.org/10.3390/ijms25010567
Vancouver
Brīvība M, Silamiķele L, Birzniece L, Ansone L, Megnis K, Silamiķelis I, et al. Gut Microbiome Composition and Dynamics in Hospitalized COVID-19 Patients and Patients with Post-Acute COVID-19 Syndrome. International Journal of Molecular Sciences. 2024;25(1):567. doi:10.3390/ijms25010567
BibTeX
@article{Brvba2024,
author = {Brīvība, Monta and Silamiķele, Laila and Birzniece, Līga and Ansone, Laura and Megnis, Kaspars and Silamiķelis, Ivars and Pelcmane, Līva and Borisova, Daniella and Rozenberga, Maija and Jagare, Lauma and Elbere, Ilze and Kloviņš, Jānis},
title = {Gut Microbiome Composition and Dynamics in Hospitalized COVID-19 Patients and Patients with Post-Acute COVID-19 Syndrome},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {1},
pages = {567},
doi = {10.3390/ijms25010567}
}
EUVIMED